En un nuevo estudio, se ha conseguido identificar una proteína, la sirtuina 7 (SIRT7), como un nuevo factor esencial para mantener la estabilidad genómica de las células germinales masculinas a lo largo del tiempo. El estudio, realizado en ratones, ha sido liderado por …
Identifican el papel de una proteína en el envejecimiento reproductivo masculino Read More »
A greater range of industrial and agricultural equipment made with the metals will temporarily face a reduced 15% levy starting June 8, per the White House.
Trump further tweaks steel, aluminum, copper tariffs Read More »
KRAS es uno de los oncogenes más frecuentemente alterados en el cáncer y está mutado en aproximadamente un tercio de los adenocarcinomas de pulmón. Durante décadas fue considerado imposible de atacar farmacológicamente, hasta la reciente aprobación de …
NewLimit is pressing the gas, speeding into clinical trials much sooner than expected after lab research showed its epigenetic reprogramming asset reversed aging in human liver cells.
NewLimit snags $435M after seeing age reversal in human liver cells Read More »
All six non-Hodgkin lymphoma patients on Legend Biotech’s CAR T therapy responded to treatment—findings that could make the biotech an attractive takeover target, according to analysts at Oppenheimer.
Legend soars on ‘best-in-class,’ ‘best-in-disease’ in vivo CAR T in early lymphoma study Read More »
Travere Therapeutics will gain an exclusive license to the oral BTK inhibitor civorebrutinib, which analysts at Guggenheim Securities said could be “complementary” to the biotech’s IgA nephropathy drug Filspari.
Travere beefs up rare kidney disease portfolio with up to $1.1B China deal Read More »
Celcuity’s gedatolisib doubled progression-free survival versus standard of care in certain patients with advanced breast cancer. Still, the biotech’s stock dropped more than 25% Tuesday.
Celcuity slides even after ‘practice-changing’ late-stage breast cancer data Read More »
El plazo para solicitar las ayudas directas termina el 30 de junio El plazo para las ayudas a placas solares en Cataluña termina en junio: ¿qué alternativas quedan? El próximo 30 de junio finaliza el plazo para solicitar las ayudas directas tradicionales vinculad …
Cierra el plazo en mayo: ¿Qué pasa con las ayudas para placas solares en Cataluña? Read More »
Improved survival on display at the American Society of Clinical Oncology (ASCO) in Chicago; Pfizer’s unusual pact with China’s Innovent highlights a new type of collaboration; Eli Lilly continues its nonstop deal streak, including with Chinese biotechs; and looking ahead to this weekend’s American Diabetes Association meeting.
ASCO wins from RevMed, Akeso/Summit, more; plus more Lilly and more China; ADA on deck Read More »
For an investment of up to $1.9 billion, Eli Lilly will be able to use Ascidian Therapeutics’ platform that removes mutated exons from mRNA molecules, avoiding the expression of disease-causing proteins.
Lilly targets kidney disease with Ascidian’s RNA exon editors for up to $1.9B Read More »
